The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of efficacy and safety of POM as a replacement therapy for lenalidomide for relapsed/refractory multiple myeloma pts refractory to a lenalidomide-containing combination regimen.
 
James R. Berenson
Employment - Oncotherapeutics; OncoTracker
Leadership - Oncotherapeutics; OncoTracker
Stock and Other Ownership Interests - Oncotherapeutics; OncoTracker
Honoraria - Variouse Pharma Companies
Consulting or Advisory Role - Variouse Pharma Companies
Speakers' Bureau - Variouse Pharma Companies
Research Funding - Institute for myeloma and Bone Cancer
Patents, Royalties, Other Intellectual Property - IMBCR and Personally
Expert Testimony - Variouse Law Firms
Travel, Accommodations, Expenses - Variouse Pharma Companies
 
Alexa Cohen
Employment - Oncotherapeutics
 
Tanya M. Spektor
Employment - Oncotherapeutics
 
Ashkan Lashkari
No Relationships to Disclose
 
Roy Mackintosh
No Relationships to Disclose
 
Alberto Bessudo
No Relationships to Disclose
 
Michael Oren Robinson
No Relationships to Disclose
 
Haresh S. Jhangiani
No Relationships to Disclose
 
Nashat Y. Gabrail
No Relationships to Disclose
 
Ibrahim Nakhoul
No Relationships to Disclose
 
Samir V. Kubba
No Relationships to Disclose
 
Jeffrey D. Neidhart
No Relationships to Disclose
 
Tina Maluso
No Relationships to Disclose
 
Regina A. Swift
Employment - Berenson Oncology
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Takeda
 
Robert A. Vescio
No Relationships to Disclose
 
Shahrooz Eshaghian
Consulting or Advisory Role - Astellas Pharma